Trxade Group Subsidiary Bonum Health Announces Prescription Savings Partnership with SingleCare
October 13 2020 - 8:05AM
Trxade Group Inc. (NASDAQ: MEDS), an integrated drug procurement,
delivery and healthcare platform, today announced that its Bonum
Health subsidiary has partnered with SingleCare, the prescription
savings service, to enhance Bonum’s enterprise telehealth solutions
with prescription discounts powered by SingleCare. The enterprise
service will be offered to national, regional and local pharmacies
to promote the benefit to uninsured patients and underserved
communities.
The increasing cost of healthcare has been
exacerbated by the economic pressures of COVID-19, especially for
the millions of recently unemployed across America. Bonum Health
enables convenient access to affordable care with its clinical
technology platform and telehealth solutions that offer virtual
medical and provider services at deeply discounted rates. Through
these telehealth solutions, an entire household can receive a
virtual consultation by board-certified medical doctors, anywhere,
at any time.
SingleCare is a free prescription savings
service that is providing millions of consumers across America with
consistently low prices to improve access and adherence to
medication. SingleCare is able to save customers up to 80% on their
prescriptions. Most people don’t realize they can shop for better
prices on their medications. SingleCare provides consistently low
prices, and it can often be cheaper than a copay – so whether or
not you have insurance, it’s always worth checking.
Bonum Health President, Ashton Maaraba, credits
the team’s innovative thinking and complementary community-driven
strategy. “The Bonum Health and SingleCare teams understand the
importance of integrating and sustaining an affordable healthcare
solution at pharmacy point-of-care. We are veterans in promoting
quality healthcare service-driven programs at the pharmacy level
and differentiate by providing transparent and affordable benefits
that pharmacy partners and their patient community can trust, “
said Maaraba.
“We’re pleased to partner with Bonum Health as
it allows us to expand our pharmacy distribution channels where
SingleCare is offered, and help more consumers with access and
adherence to affordable medication,” said John Zevzavadijan,
President of Enterprise Platform Services at SingleCare.
About SingleCare
SingleCare®️ is a free prescription savings
service that provides consistently low prices to improve access and
adherence to medication. It handles hundreds of thousands of
prescriptions per day and is helping millions of people across the
U.S. save a significant amount of money on their prescriptions.
Through a combination of innovative technology and direct contracts
with pharmacies, SingleCare allows consumers to access prescription
savings at pharmacies near them via the mobile app or discount
cards available on SingleCare.com. SingleCare partners with the
country’s leading pharmacy companies covering 35,000 pharmacies
nationwide. SingleCare is headquartered in Boston with offices in
New York City, greater Philadelphia and West Palm Beach, Fla. For
more information, visit singlecare.com or download SingleCare on
iOS or Android.
About Trxade
Group, Inc.
Headquartered in Tampa, Florida, Trxade Group,
Inc. (Nasdaq: MEDS) is an integrated drug procurement,
delivery and healthcare platform that fosters price transparency,
thereby improving profit margins for both buyers and sellers of
pharmaceuticals. Trxade Group operates across all 50 states with
the central mission of making healthcare services affordable and
accessible. Founded in 2010, Trxade Group is comprised of three
synergistic operating platforms; (1) the Trxade B2B trading
platform with around 11,800 registered pharmacies, (2) Integra
Pharma Solutions, Trxade Group’s virtual wholesale division, and
(3) the Bonum Health platform offering affordable telehealth
services. For additional information, please visit us at
www.trxade.com or at www.bonumhealth.com.
Forward-Looking Statements
This press release may contain forward-looking
statements, including information about management’s view of
Trxade’s future expectations, plans and prospects, within the safe
harbor provisions under The Private Securities Litigation Reform
Act of 1995 (the “Act”). In particular, when used in the preceding
discussion, the words “may,” “could,” “expect,” “intend,” “plan,”
“seek,” “anticipate,” “believe,” “estimate,” “predict,”
“potential,” “continue,” “likely,” “will,” “would” and variations
of these terms and similar expressions, or the negative of these
terms or similar expressions are intended to identify
forward-looking statements within the meaning of the Act, and are
subject to the safe harbor created by the Act. Any statements made
in this news release other than those of historical fact, about an
action, event or development, are forward-looking statements. These
statements involve known and unknown risks, uncertainties and other
factors, which may cause the results of Trxade, its divisions and
concepts to be materially different than those expressed or implied
in such statements. These risk factors and others are included from
time to time in filings made by Trxade with the Securities and
Exchange Commission, including, but not limited to, in the “Risk
Factors” sections in its Form 10-Ks and Form 10-Qs and in its Form
8-Ks, which it has filed, and files from time to time, with the
U.S. Securities and Exchange Commission. These reports are
available at www.sec.gov. Other unknown or unpredictable
factors also could have material adverse effects on Trxade’s future
results and/or could cause our actual results and financial
condition to differ materially from those indicated in the
forward-looking statements. The forward-looking statements included
in this press release are made only as of the date hereof. Trxade
cannot guarantee future results, levels of activity, performance or
achievements. Accordingly, you should not place undue reliance on
these forward-looking statements. We undertake no obligation to
update publicly any of these forward-looking statements to reflect
actual results, new information or future events, changes in
assumptions or changes in other factors affecting forward-looking
statements, except to the extent required by applicable laws. If we
update one or more forward-looking statements, no inference should
be drawn that we will make additional updates with respect to those
or other forward-looking statements.
Investor Relations: Luke
Zimmerman Senior Vice President MZ Group - MZ North America (949)
259-4987 MEDS@mzgroup.us www.mzgroup.us
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Mar 2024 to Apr 2024
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Apr 2023 to Apr 2024